Duff & Phelps Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-22,021
Closed -$2.01M 230
2019
Q2
$2.01M Sell
22,021
-43,990
-67% -$3.72M 0.03% 159
2019
Q1
$5.69M Buy
66,011
+9,306
+16% +$747K 0.09% 121
2018
Q4
$4.36M Buy
+56,705
New +$4.41M 0.07% 131

Other funds holding NVS

Duff & Phelps Investment Management's NVS Position: Q3 2019 in Review

Duff & Phelps Investment Management sold out of Novartis (NVS) in Q3 2019, closing a stake of 22,021 shares — an estimated $2.01M sold.

Duff & Phelps Investment Management first reported a position in NVS in Q4 2018 and held it in 3 quarters. The position peaked at $5.69M in Q1 2019. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • Duff & Phelps Investment Management reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • Duff & Phelps Investment Management sold 22,021 Novartis shares in Q3 2019, an estimated $2.01M.
  • Duff & Phelps Investment Management first reported a position in Novartis in Q4 2018 and held it in 3 quarters.
  • Duff & Phelps Investment Management's Novartis position peaked at $5.69M in Q1 2019.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Duff & Phelps Investment Management's 13F filing for Q3 2019, filed 16 Oct 2019.